Literature DB >> 27201181

Exploring Uncertainty in Economic Evaluation Of Medicines: A Review of The First Manufacturers' Submissions To the French National Authority For Health (Has).

S Ghabri1, F F Hamers1, J M Josselin2, J L Harousseau1.   

Abstract

Year:  2014        PMID： 27201181     DOI： 10.1016/j.jval.2014.08.1160

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  3 in total

Review 1.  Cost-effectiveness of cardiac resynchronization therapy plus an implantable cardioverter-defibrillator in patients with heart failure: a systematic review.

Authors:  Abedin Teimourizad; Aziz Rezapour; Saeed Sadeghian; Masih Tajdini
Journal:  Cost Eff Resour Alloc       Date:  2021-05-21

2.  Cost-effectiveness of coronary artery bypass graft and percutaneous coronary intervention compared to medical therapy in patients with coronary artery disease: a systematic review.

Authors:  Saeed Sheikh Gholami; Farbod Ebadi Fard Azar; Aziz Rezapour; Masih Tajdini
Journal:  Heart Fail Rev       Date:  2019-11       Impact factor: 4.214

3.  Cost-effectiveness of B-type natriuretic peptide-guided care in patients with heart failure: a systematic review.

Authors:  Abdosaleh Jafari; Aziz Rezapour; Marjan Hajahmadi
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.